Malignant effusive disease of the pleura and pericardium.

Malignant pleural and pericardial effusions are a common problem in the treatment of patients with lung cancer, breast cancer, or lymphoma and may occur with any malignancy. These effusions are frequently symptomatic and, in the case of the pleural space, may be the presenting sign of cancer. In other patients, they represent markers of recurrent, disseminated, or advanced disease. Given the poor prognosis of most patients presenting with these effusions, reducing symptoms and improving quality of life are the primary goals of treatment. Permanent drainage and/or obliteration of the pleural or pericardial space are crucial to the effective management of the effusion and will provide long-term palliation. Immediate relief can be accomplished via external drainage, but definitive therapy may often also require interventional radiology, cardiology, and thoracic surgery, as well as medical and radiation oncology. The pathophysiology, diagnosis, and treatment of malignant pleural and pericardial effusions are discussed in this article.

[1]  C. O'connor,et al.  A Prospective Trial of Subxiphoid Pericardiotomy in the Diagnosis and Treatment of Large Pericardial Effusion A Follow‐Up Report , 1993, Annals of surgery.

[2]  P. Pfitzer,et al.  Blind pleural biopsy in combination with cytology of pleural effusions. , 1981, Acta cytologica.

[3]  S J Mentzer,et al.  The safety and versatility of video-thoracoscopy: a prospective analysis of 895 consecutive cases. , 1996, Journal of the American College of Surgeons.

[4]  M. Tattersall,et al.  Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients , 1991, The Medical journal of Australia.

[5]  M. LeWinter,et al.  Treatment of malignant pericardial effusion. , 1994, JAMA.

[6]  Jeffrey S. Ginsberg,et al.  Tetracycline sclerosis in the management of malignant pericardial effusion. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  W. C. Ball,et al.  Pleural effusions: the diagnostic separation of transudates and exudates. , 1972, Annals of internal medicine.

[8]  A. Haubek,et al.  The diagnostic value of pericardial cytology. An analysis of 95 cases. , 1991, Acta cytologica.

[9]  M. Bains,et al.  Indications for pleurectomy in malignant effusion , 1975, Cancer.

[10]  H. Schaff,et al.  Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course. , 1985, The Journal of thoracic and cardiovascular surgery.

[11]  Y. Erozan,et al.  Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. , 1975, Chest.

[12]  P. Moulder,et al.  Iodized talc pleurodesis for the treatment of pleural effusions. , 1992, The Journal of thoracic and cardiovascular surgery.

[13]  J. Ruckdeschel,et al.  Management of malignant pleural effusion: an overview. , 1988, Seminars in oncology.

[14]  R. Frater,et al.  The subxiphoid approach in the treatment of pericardial effusion. , 1977, The Annals of thoracic surgery.

[15]  K. Kesler,et al.  Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. , 1993, The Journal of thoracic and cardiovascular surgery.

[16]  Y. Ichinose,et al.  A simple technique to manage malignant pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. , 1994, Oncology.

[17]  Black Lf.  The pleural space and pleural fluid. , 1972 .

[18]  G. Dewald,et al.  Usefulness of chromosome examination in the diagnosis of malignant pleural effusions. , 1976, The New England journal of medicine.

[19]  J. Conn,et al.  Re-expansion pulmonary edema. , 1973, Chest.

[20]  E. C. Leuallen,et al.  Pleural effusion; a statistical study of 436 patients. , 1955, The New England journal of medicine.

[21]  M. F. Michelis,et al.  Management of acute cardiac tamponade by subxiphoid pericardiotomy. , 1982, JAMA.

[22]  J. Woodring.  Recognition of pleural effusion on supine radiographs: how much fluid is required? , 1984, AJR. American journal of roentgenology.

[23]  I. Fentiman,et al.  A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. , 1986, European journal of cancer & clinical oncology.

[24]  S. Sahn,et al.  Carcinomatous involvement of the pleura: an analysis of 96 patients. , 1977, The American journal of medicine.

[25]  A. Kuten,et al.  Cytologic analysis of pericardial effusion complicating extracardiac malignancy. , 1992, The American journal of cardiology.

[26]  W. Fleming,et al.  Intrapleural doxycycline control of malignant pleural effusions. , 1993, The Annals of thoracic surgery.

[27]  A. Theologides.  Neoplastic cardiac tamponade. , 1978, Seminars in oncology.

[28]  A. Little,et al.  Pericardial window: mechanisms of efficacy. , 1990, The Annals of thoracic surgery.

[29]  I. Fentiman,et al.  Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast , 1989, The British journal of surgery.

[30]  J. Bennett,et al.  Management of malignant pleural effusion , 1978, Journal of surgical oncology.

[31]  M. Mack,et al.  Thoracoscopic pericardiectomy for effusive pericardial disease. , 1993, The Annals of thoracic surgery.

[32]  P. B. Stewart.  The rate of formation and lymphatic removal of fluid in pleural effusions. , 1963, The Journal of clinical investigation.

[33]  F. Shepherd,et al.  Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. , 1996, The Journal of thoracic and cardiovascular surgery.

[34]  Chambers Js.  Palliative treatment of neoplastic pleural effusion with intercostal intubation and talc instillation. , 1958 .

[35]  T B Ferguson,et al.  The treatment of malignant pleural effusions , 1974, Cancer.